PCR & Real-time PCR Molecular Diagnostics Market: Introduction
Transparency Market Research has published a new report titled, ‘Global PCR & Real-time PCR Molecular Diagnostics Market’. According to the report, the global PCR & real-time PCR molecular diagnostics market was valued over US$ 4.1 Bn in 2019. It is projected to expand at a CAGR of ~4% from 2020 to 2030. Polymerase chain reaction (PCR) is used to amplify or make copies of deoxyribonucleic acid (DNA) sequence of interest. It is utilized in various applications including DNA cloning, diagnosis of hereditary diseases, functional analysis of genes, paternity testing, detection of infectious diseases, and forensic sciences. The polymerase chain reaction (PCR) technique is also used in DNA sequencing, cloning, library generations, mutagenesis, and expression profiling. PCR amplifies DNA by copying the nucleic acid strands. Thermal cyclers are employed to denature and anneal DNA strands during amplification, along with reagents such as enzymes, nucleotides, and buffers to build the novel DNA. However, technological advancements and high demand for automate workstations have increased the adoption of real-time PCR and digital PCR techniques in busy, high-throughput laboratories to simplify workflow.
Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=79197
PCR & Real-time PCR Molecular Diagnostics: Market Segmentation
In terms of technology, the global PCR & real-time PCR molecular diagnostics market has been classified into traditional PCR, real-time PCR, and digital PCR. The real-time PCR segment accounted for a notable share of the market in 2019. It is projected to maintain is dominance during the forecast period. The segment is expected to be driven by the rise in awareness about PCR based diagnostic techniques and an increase in the demand for real-time-based technologically advanced molecular diagnostics solutions.
In terms of application, the market has been segmented into infectious diseases testing, oncology testing, genetic testing, and others. The infectious disease testing segment has been further categorized into HCV & HBV, sexually transmitted infections, hospital acquired infections, respiratory infections, and others. The infectious disease testing segment is projected to be drive by increase in prevalence of HIV & respiratory infections and rise in the demand for molecular diagnosis for COVID-19.Based on end user, the global PCR & real-time PCR molecular diagnostics market has been divided into hospitals, diagnostic laboratories, academic & research centers, and others. The hospitals segment held a major share of the global market in 2019, owing to increase in focus on providing quality care, rise in emphasis on early diagnostics of diseases, and surge in the number of well-equipped specialty hospitals.
Request COVID Analysis on PCR & Real-time PCR Molecular Diagnostics Market –https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=79197
PCR & Real-time PCR Molecular Diagnostics Market: Prominent Regions
North America held a major share of the global PCR & real-time PCR molecular diagnostics market in 2019. Recent product approvals by the Food and Drug Administration (FDA), technological advancements, and expansion of the molecular diagnostic industry are key factors driving the market in the region. Europe followed North America, in terms of share of the global PCR & real-time PCR molecular diagnostics market in 2019. The expansion of the PCR & real-time PCR molecular diagnostics market in the region can be attributed to rapid adoption of latest PCR technology systems, increase in prevalence of infectious diseases, and growing focus on research & development activities. According to an article published by the Swiss Medical Weekly, chronic infection with HCV and HBV are major health concerns in countries across Europe; moreover, due to the prevalence of HCV varies across Europe.
Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=79197
PCR & Real-time PCR Molecular Diagnostics Market: Key Players
Leading players are expanding their footprint to strengthen their position in the global PCR & real-time PCR molecular diagnostics market. Development of innovative PCR technologies for diagnosis of cancer, new product launch, technological advancements, and geographic expansion by prominent market players are likely to offer lucrative opportunities in the global PCR & real-time PCR molecular diagnostics market.
Key players operating in the global PCR & real-time PCR molecular diagnostics market include Abbott Laboratories, Bio-Rad Laboratories, Inc., bioMérieux SA, Danaher Corporation, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd , QIAGEN N.V., Hologic, Inc., GRIFOLS, S.A., Genomic Health, and Seegene, Inc.
About Us Section:
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
Contact Us
Mr. Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/
